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Over the last decade, there has been an increasing attention to the role played by
emotional processes in Parkinson’s disease (PD). However, most of what is known in
this area is based on research conducted in laboratory or clinical settings. In this article,
the authors underline the need to expand our current knowledge of the psychological
correlates of PD by investigating patients’ everyday emotions in natural contexts.
Specifically, the authors illustrate new research avenues based on the implementation
of experience sampling methods. It is argued that these methods could permit future
researchers to ecologically assess the frequency and intensity with which parkinsonian
patients experience specific emotions (either negative or positive) during their everyday
life, providing at the same time precious information on what are the most typical
situations in which these emotions occur and on how patients behave in these
circumstances. Potential practical implications associated with investigating these issues
are discussed.
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Parkinson’s disease (PD) is a neurodegenerative disorder associ-
ated with the loss of dopamine-producing neurons in the pars
compacta region of the substantia nigra. The cardinal symp-
toms of the disease are tremor, muscular rigidity, bradykinesia
(i.e., slowness of movement), and postural instability. These
motor impairments are often accompanied by a wide range of
non-motor symptoms (e.g., depression, executive dysfunctions,
concentration difficulty, sleep disturbances, weight loss, auto-
nomic impairments), both symptom categories having a great
impact on the quality of PD patient’s life (Schrag et al., 2000;
Martinez-Martin et al., 2011).
Over the last decade, there has been an increasing attention to
the role played by emotional processes in PD. Psychologists and
neuroscientists have made important progresses in understand-
ing how PD impairs specific components of emotional processes
(e.g., expressive, cognitive, subjective) and have also formulated
interesting hypotheses about the underlying neurological mecha-
nisms which could explain the emotional impairments observed
in PD patients (for recent reviews, see Blonder and Slevin, 2011;
Péron et al., 2012). While the theoretical and empirical work
done so far has been very precious, we believe that the research
on the emotional aspects of PD is only at the beginning and
researchers have the opportunity to gain more information on
this topic.
The main aim of the present article is to delineate unex-
plored research directions for investigators studying the emo-
tional aspects of PD. In the following, we first briefly summarize
what researchers already know about emotional processes affected
by PD. Then, we critically discuss the most important limita-
tions of the current empirical literature and present a potential
new research area which could advance our understanding of the
emotional processes in PD.
CURRENT RESEARCH AREAS
Researchers investigating emotions in PD have devoted much of
their efforts in three major areas: (1) Facial and vocal expression
of emotion, (2) recognition of emotional stimuli, (3) changes in
PD patients’ affective tone and mood. Let’s consider the main
results obtained in each area.
FACIAL AND VOCAL EXPRESSION OF EMOTION
Researchers working within this area designed well-controlled
laboratory studies in order to investigate how PD patients express
emotions in the face and voice. Overall, it has been found that the
expression abilities of PD patients are significantly compromised.
For example, Simons et al. (2003) assessed the facial activity of 22
PD patients and 22 healthy control participants using the Facial
Action Coding System (FACS; Ekman and Friesen, 1978). Results
showed that PD patients exhibited reduced levels of spontaneous
and voluntary expressions in response to unpleasant olfactory
stimuli as compared with controls. Similarly, Möbes et al. (2008)
employed a software for speech analysis (PRAAT; Boersma and
Weenink, 1996) to assess the productions of emotional prosody
in 16 PD patients (with no signs of dysarthria) and 16 con-
trols, both groups being matched for age, gender, and education.
More in detail, subjects participating in this study were asked
to produce the name “Anna” using a specific emotional intona-
tion (i.e., happy, sad, or neutral). Findings indicated that patients
with PD showed smaller pitch and loudness ranges than con-
trols, thus performing worse in this task; however, the two groups
did not significantly differ in two supplementary tasks assessing
their phonation capacity and their ability to imitate a professional
speaker. On the basis of these results, Möbes et al. concluded that
motor impairment is not a sufficient condition to explain changes
of emotional speech in PD patients.
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RECOGNITION OF EMOTIONAL STIMULI
The investigation of emotion recognition skills in parkinso-
nian patients is probably the most representative research area
within the emotion literature on PD. Indeed, a huge num-
ber of studies have been conducted in the last years with the
goal to understand if PD patients dealing with different dis-
ease stages are still able to correctly identify, discriminate, and
rate the emotional content of stimuli (e.g., pictures, prerecorded
speech samples, written sentences) presented in laboratory set-
tings. Unfortunately, the data collected so far are inconsistent and
quite difficult to interpret: whereas some researchers reported
that PD patients perform worse than controls in a number of
recognition tasks, there is also evidence that the two groups
do not significantly differ in the same tasks (for reviews, see
Assogna et al., 2008; Schröder et al., 2010; Péron et al., 2012).
A recent meta-analysis by Gray and Tickle-Degnen (2010) has
shed some lights on this controversial point. These authors
examined the magnitude of the association between PD and
deficits in emotion recognition using data from 34 indepen-
dent comparisons, which involved a total of 1295 participants
(594 individuals with PD and 701 controls). It emerged that
about 75% of the comparisons evidenced a significantly poorer
performance among the parkinsonian patients relative to the
controls. When looking at the factors moderating the partic-
ipants’ emotion recognition abilities, Gray and Tickle-Degnen
found that PD groups were more impaired in recognizing emo-
tion from prosodic stimuli than from facial displays. Moreover,
it was found that the performances of PD patients were poorer
when the stimuli to be recognized referred to negative emotions
(e.g., anger, disgust, sadness) as compared to positive ones (e.g.,
happiness).
CHANGES IN AFFECTIVE TONE AND MOOD
This research area concerns the complex changes in affective
tone and mood of PD patients. Recent prevalence studies (e.g.,
Aarsland et al., 2007; Kulisevsky et al., 2008; Nègre-Pagès et al.,
2010; Siri et al., 2010) have documented that patients with PD fre-
quently report or exhibit signs of anxiety, apathy, and depressed
mood. These emotional dysfunctions may affect up to 70% of PD
patients, in some cases taking the form of psychopathological syn-
dromes with a clinical significance and requiring pharmacological
and psychological treatment. Importantly, it has been suggested
that some patients may experience significant affective and mood
changes as a result of surgical treatments of PD. In particular,
depression and anxiety have been reported following deep brain
stimulation of the subthalamic nucleus (e.g., Berney et al., 2002;
Houeto et al., 2002; Perriol et al., 2006). However, these compli-
cations seem more likely in patients with preoperative emotional
dysfunctions (for reviews, see Temel et al., 2006; Bronstein et al.,
2011).
Although there are PD patients exhibiting very specific
emotional dysfunctions, it has been demonstrated that a sig-
nificant proportion of parkinsonian individuals receive comor-
bid diagnoses, with depression-apathy and depression-anxiety
co-occurring most frequently (on this topic, see for example
Dissanayaka et al., 2010; Oguru et al., 2010). Interestingly, in a
study conducted on a group of 58 PD patients without dementia,
Costa et al. (2006) found that individuals with high levels of
depression weremore likely to display features of alexithymia (i.e.,
alteration of the ability to describe and identify one’s feelings,
and to distinguish feelings from bodily sensations of emotional
arousal; cf. Taylor et al., 1991). However, more recent inves-
tigations comparing PD patients and control subjects (Costa
et al., 2010; Assogna et al., 2012) have suggested that depression
and alexithymia might be independent disorders in PD. There
is also empirical evidence that depressive symptoms may pre-
cede the onset of PD. For example, Leentjens et al. (2003) used
data from a computerized practice-based register to calculate the
incidence of depression in a group of 338 Dutch citizens later
diagnosed with PD. Results showed that, at the time of diagno-
sis of PD, 9.2% of the PD patients had a history of depression
relative to 4.0% of a matched control population; the differ-
ence in incidence was statistically significant. These findings,
along with other ones reported in epidemiological studies con-
ducted with similar methods (e.g., Nilsson et al., 2002; Fang
et al., 2010), suggest that depressed mood may constitute either
a symptom or a risk factor for PD (cf. Blonder and Slevin,
2011).
In concluding this section, we would like to remark that
while the here used concepts of affective tone and mood are
not exactly equivalent to the one of emotion, all these con-
cepts refer to strongly interconnected phenomena, as prolonged
emotions tend to transform into mood-like and affective states
(see, Plutchik, 1994). Furthermore, the self-report instruments
which are commonly used to assess mood and affective alter-
ations in PD populations—for example, the Beck Depression
Inventory (Beck et al., 1996) or the Spielberger State-Trait
Anxiety Inventory (Spielberger et al., 1983)—explicitly refer to
the patients’ everyday emotions such as worry, sadness, guilt, and
interest.
FUTURE DIRECTIONS: STUDYING THE EVERYDAY
EMOTIONAL LIFE OF PD PATIENTS USING EXPERIENCE
SAMPLING METHODS
Altogether, the studies reviewed in the previous section clearly
show that PD negatively influences the affective life of patients
suffering from this disorder.More in detail, research on emotional
expressions suggests that PD patients may exhibit significant
deficits in the non-verbal communication, having difficulties
in producing both emotional facial movements and affective
prosody. Moreover, it has been demonstrated that patients with
PD may display deficits in performing emotion recognition
tasks in laboratory settings: this seems particularly true for
experimental tasks involving prosodic stimuli with a negative
valence. Lastly, a great number of studies have shown that PD
patients frequently experience mood alterations and emotional
dysfunctions, including depression, apathy, anxiety, as well as
alexithymia.
From what has been said so far, it appears that investigat-
ing the emotional consequences of PD may shed light on the
complex relationship between the neurobiological and the psy-
chological aspects of the disease. However, a closer examination
of the available literature reveals that there are some relevant
issues which have not yet been explored. With this regard, we note
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that although researchers have documented that PD is associated
with significant changes in the overall affective tone and mood of
patients, to the best of our knowledge there have been no studies
aimed at investigating the quality of their everyday emotional life.
In our opinion, there is urgency to understand how parkinsonian
individuals psychologically adapt to their disease and emotionally
respond to the diverse stimuli which characterize their every-
day life environment. Indeed, it is undeniable that both motor
and non-motor symptoms, as well as the therapeutic interven-
tions aimed at reducing their severity, dramatically influence the
emotional life of people suffering from PD. Based on these con-
siderations, we believe that it would be important to empirically
determine the frequency and the intensity with which PD patients
experience specific categories of emotions—either negative (e.g.
fear, sadness, anger, disgust) or positive (e.g., joy, contentment,
relief, hope)—in their daily life. We also argue that researchers
would greatly benefit from knowing what are the most typical
situations in which PD patients experience negative and positive
emotions, how individuals with PD behave in these situations,
and how everyday emotional experiences might affect the phys-
ical and psychological well-being of patients over time. From a
methodological point of view, we propose the introduction of
research methods able to assess the content of patients’ emo-
tional experiences and the contextual factors associated with these
experiences. In particular, a promising approach could be the
use of experience sampling methods (for an overview, see Bolger
et al., 2003; Mehl and Conner, 2011). Hereafter, we describe what
these methods consist of and how they could be usefully applied
with the goal to investigate the PD patients’ everyday emotional
life.
Different from other research methodologies frequently
employed in the study of everyday emotional life (e.g., ret-
rospective questionnaires; see Scherer et al., 2004), the expe-
rience sampling methods allow researchers to assess people’s
emotional experiences on line (i.e., while they are actually hap-
pening) or shortly after (some minutes or hours) from their
occurrence. More in detail, researchers following this approach
ask participants to record events they have personally experi-
enced during their everyday life, answering written questions
concerning both their emotional reactions to what happened
and the specific situational context in which the recorded events
occurred. Generally, this information is gathered by means of
paper-and-pencil diaries or booklets (Zelenski and Larsen, 2000;
Brandstätter, 2001; Vansteelandt et al., 2005; Nezlek et al., 2008).
However, recent studies—typically conducted in non-clinical
samples (e.g., Pe and Kuppens, 2012)—have introduced palm-
top computers, serving the same functions of paper-and-pencil
self-report instruments (on this topic, see Barrett and Barrett,
2001; Le et al., 2006). Importantly, researchers using experience
sampling methods have to carefully choose an appropriate sam-
pling protocol that is, they have to establish the criteria according
to which participants will select and report their experiences
(e.g., closely following a target event, at fixed times through-
out the day, in response to a random signal). Furthermore,
decisions must be taken on the length of the whole sampling
period, namely how long the participants will have to record
their experiences (e.g., 1 day, 3 days, 1 week, 1 month). When
taking all these decisions, researchers should pay special attention
to the specific objectives of their experience sampling study.
Other important factors to be taken into account include the
burden to participants and the prevalence of the target events
and psychological states under investigation (for a detailed dis-
cussion, see Reis and Gable, 2000; Conner Christensen et al.,
2003).
Although it is undeniable that experience sampling methods
may pose significant obstacles to both researchers and study par-
ticipants (on this issue, see Scollon et al., 2003), we argue that
the application of this approach to parkinsonian populations
could bring significant advantages. The most important benefit
is the ecological validity of the studies implementing experience
sampling methods. As we have noted in the first part of this
article, our current knowledge of the emotional aspects of PD
mainly comes from studies conducted in laboratory and clin-
ical settings. However, since these contexts significantly differ
from real life, the generalizability of findings obtained from this
research is limited. Contrary to this, experience sampling meth-
ods allow researchers to assess emotional processes and affective
states occurring in natural settings, thus permitting greater gen-
eralizability of their results. A second advantage associated with
the use of experience sampling methods in PD research con-
cerns the possibility to investigate the contingencies between
the emotional experiences occurring in the life of PD patients
and specific disease-related factors such as, for instance, tak-
ing dopamine agonist drugs, dealing with motor fluctuations,
performing a rehabilitation activity, and so on. Finally, it is
well-known that experience sampling methods permit to reduce
memory fallacies, social desirability tendencies, and other biased
response patterns which are typically related to the use of tradi-
tional self-report measures (cf. Bolger et al., 2003; Scollon et al.,
2003). With this respect, two experimental studies by Smith et al.
(2006) employed survey methods to investigate how PD patients
assess their satisfaction with life and health. It was found that
judgments formulated by the participants significantly varied as
a function of how experimenters introduced the study. In our
opinion, these results strongly suggest to consider with caution
data on PD patients’ quality of life collected in the context of
survey research.
In the light of the abovementioned advantages, we argue that
researchers should use experience sampling methods to investi-
gate the everyday emotional life of parkinsonian patients who
are facing different clinical conditions: for instance, patients
newly diagnosed with PD who have never received pharma-
cological treatment (they are typically called de novo patients);
patients taking dopamine agonist medications and exhibit-
ing frequent and intense motor fluctuations; pharmacologically
treated patients showing both motor and non-motor fluctu-
ations; patients who do not exhibit disease-related symptoms
because they are positively responding to the treatment with
antiparkinsonian drugs; patients submitted to deep brain stim-
ulation surgery. We believe that the comparison between these
patient categories might allow researchers to better describe how
the emotional life of parkinsonian patients changes in the var-
ious disease stages, providing at the same time precious infor-
mation about the contextual factors which are able to affect
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these transformations. From a methodological point of view,
these research aims could be best attained implementing both
cross-sectional and longitudinal designs. Specifically, longitudi-
nal studies could offer the researchers the opportunity to analyze
changes in the everyday emotional life of PD patients at the
within-person level. This would also permit to better understand
the efficacy of pharmacological and surgical treatments over time
and, more generally, the progression of disease.
Of course, researchers conducting experience sampling studies
in parkinsonian groups should carefully adapt their methodol-
ogy to the specific characteristics of the study participants they
are investigating. For instance, if it has been planned to conduct
a study of pharmacologically treated patients with severe motor
fluctuations, it would be recommendable to give the participants
the opportunity to report their emotional experiences shortly
after their “off” phases (cf. Hughes et al., 1994), thus reduc-
ing the burden of research assessments. Importantly, researchers
should also evaluate how to best collect patients’ self-reports: for
instance, while palmtop computers may be unsuitable for older
patients, these instruments could be fruitfully implemented in
studies of younger patients. Lastly, great attention should be paid
in defining experience sampling protocols that are appropriate
with respect to the patients’ disease stage.
CONCLUSION
To conclude, we note that investigating the everyday emotional
life of PD patients could advance our understanding of the
psychological aspects of PD, providing at the same time precious
indications on how to support people suffering from this dis-
order. Indeed, knowing in which situations and circumstances
PD patients experience negative emotions such as anger, sadness,
anxiety, and shame, could shed insight into the main difficulties
and obstacles these individuals face in their everyday life. On the
other hand, knowing in which situations and circumstances PD
patients experience positive emotions such as joy, contentment,
serenity, and interest, could facilitate the identification of the con-
textual factors which are presumably associated with higher levels
of quality of life and subjective well-being. At a practical level, this
knowledge may be used to design and implement psychological
interventions targeting both the PD patients and their caregivers.
Such interventions should be aimed at promoting an improved
ability to read and interpret the meaning of the emotions that
occur in everyday life. This is another way to help patients and
their caregivers to use emotions as valuable tools through which
they could not only identify the risks and threats of their environ-
ment, but also discover and get in touch with its resources and
opportunities.
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